Fri.Jun 12, 2020

article thumbnail

What Pharmaceutical Marketers Can Learn from the Coronavirus Response

Pharma Marketing Network

Many of us are now working from home. We’re accepting meeting invites that will be held via video conference and preparing to FaceTime our families after work. We are pivoting our lifestyles to fit the circumstances that COVID-19 has put us in. After lockdowns, isolations, and closures, we are starting to see the nation prepare to reopen. While New York City was one of the most severe areas for the pandemic, other regions of the state are ready to leave isolation.

article thumbnail

HIPAA & PHI Best Practices for Patient Recruitment Solution Implementation on Salesforce

Cloudbyz

The purpose of this document is to outline some of the HIPAA Security Rule’s standards for protecting electronic protected health information (ePHI), and introduce how some features of the Salesforce Services may help Customers keep ePHI secure in the cloud and considerations on solution implementation approach covering Salesforce Marketing Cloud, Salesforce Health Cloud, and Salesforce Community Cloud for the purposes of early phase clinical trials patient recruitment solution.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Ripple Effect of Medication Access Barriers—Disruption to Stakeholder Workflows, Damage to Brand Perception, and Detriment to Innovation

Drug Channels

Today’s guest post comes from Julia Phillips, VP, Pharma Accounts & Enablement at CoverMyMeds. Julia discusses how medication access challenges can negatively impact brand-name drugs. For more, check out this overview of CoverMyMeds' technology solutions that enhance patients’ access: Enabling Medication Access Through Technology. Read on for Julia’s insights.

article thumbnail

WHO Needs to Study Online Pharmacy Drug Safety

Pharmacy Checkers

Generally, I strongly support the World Health Organization (WHO) and its unambiguously important work to save lives through its public health efforts. The backlash against it in the U.S. is simultaneously misguided and politically motivated. I know why. It detracts from our failures in the U.S. to save lives, but there is more to the story. Republicans generally have a greater hostility to international organizations because they view them as tying our hands and/or taking our money to help peop

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time